[Clinical significance of long-acting anti-anginal drugs in the treatment of cardiovascular diseases].
Watanabe
H
H
Cardiovascular Institute.
Kato
K
K
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy* / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004361:Drug Tolerance; D006801:Humans; D007548:Isosorbide Dinitrate / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005996:Nitroglycerin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D003692:Delayed-Action Preparations; D005996:Nitroglycerin; D007548:Isosorbide Dinitrate